Financial Ratios

GUJARAT THEMIS BIOSYN LTD.

NSE : NABSE : 506879ISIN CODE : INE942C01045Industry : Pharmaceuticals & DrugsHouse : Private
BSE385.802.75 (+0.72 %)
PREV CLOSE ( ) 383.05
OPEN PRICE ( ) 376.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 48873
TODAY'S LOW / HIGH ( )375.40 390.00
52 WK LOW / HIGH ( ) 144.82410
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)39.9030.0320.7716.304.41
   CEPS(Rs)8.336.314.393.451.05
   DPS(Rs)5.4011.000.001.650.00
   Book NAV/Share(Rs)102.6671.1248.1429.0412.75
   Tax Rate(%)25.1726.1026.1824.2621.80
Margin Ratios
   Core EBITDA Margin(%)49.8250.5444.5337.4017.93
   EBIT Margin(%)52.1352.1246.2337.8020.35
   Pre Tax Margin(%)52.0051.4045.1436.7219.96
   PAT Margin (%)38.9137.9833.3227.8115.61
   Cash Profit Margin (%)40.6439.9335.2429.4118.59
Performance Ratios
   ROA(%)35.8137.0835.6545.6224.07
   ROE(%)45.9250.3553.8277.9941.85
   ROCE(%)61.5367.9167.8985.9644.88
   Asset Turnover(x)0.920.981.071.641.54
   Sales/Fixed Asset(x)4.124.273.824.252.65
   Working Capital/Sales(x)3.271.881.917.22-8.60
Efficiency Ratios
   Fixed Capital/Sales(x)0.240.230.260.240.38
   Receivable days52.7163.2970.4255.8037.88
   Inventory Days32.1328.0624.3413.653.55
   Payable days114.42115.10132.50215.311966.91
Valuation Parameters
   PER(x)17.2013.579.805.968.91
   PCE(x)16.4712.919.275.647.48
   Price/Book(x)6.695.734.233.353.08
   Yield(%)0.792.700.001.700.00
   EV/Net Sales(x)6.635.053.001.731.50
   EV/Core EBITDA(x)12.319.336.224.396.41
   EV/EBIT(x)12.729.686.484.587.35
   EV/CE(x)5.294.232.762.071.87
   M Cap / Sales6.695.153.271.661.39
Growth Ratio
   Net Sales Growth(%)29.7126.826.39107.375.80
   Core EBITDA Growth(%)29.2242.4329.97250.3049.51
   EBIT Growth(%)29.7442.9930.09285.2058.95
   PAT Growth(%)32.8844.5527.48269.4065.73
   EPS Growth(%)32.8844.5527.47269.4065.73
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.040.190.32
   Current Ratio(x)2.282.932.841.490.63
   Quick Ratio(x)1.872.572.601.240.60
   Interest Cover(x)386.9772.3142.6634.8552.71
   Total Debt/Mcap(x)0.000.000.010.060.11

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.